NOVAREX Co.,Ltd. (KOSDAQ:194700)
South Korea · Delayed Price · Currency is KRW 9,560.00
-190.00 (-1.95%)
At close: Oct 23, 2026
NOVAREX Market Cap
NOVAREX has a market cap or net worth of 164.45 billion as of October 23, 2026. It is the 23,559th most valuable company in the world and the 930th biggest in South Korea. Its market cap has decreased by 48.90% in one year.
Market Cap
164.45B
Enterprise Value
152.20B
Revenue
404.26B
Global Rank
Country Rank
#930 South Korea
PE Ratio
4.78
ChartMarket Cap Chart
Since November 14, 2018, NOVAREX's market cap has decreased from 180.98B to 164.45B, a decrease of -9.13%. That is a compound annual growth rate of -1.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 164.45B | -33.64% |
| Dec 30, 2025 | 247.83B | 86.67% |
| Dec 30, 2024 | 132.77B | -38.22% |
| Dec 28, 2023 | 214.90B | 19.61% |
| Dec 29, 2022 | 179.68B | -41.23% |
| Dec 30, 2021 | 305.72B | -1.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HEM Pharma | 215.19B |
| GC WellBeing | 195.54B |
| DAE HWA Pharmaceutical | 189.94B |
| Vivozon Pharmaceutical | 185.31B |
| CellBion | 165.32B |
| Kyung Dong Pharmaceutical | 146.79B |
| HYUNDAI BIOLAND | 133.20B |
| PHARMARESEARCH BIO | 121.87B |